Abstract
Recent animal work has documented a two-way interconnection between calvarial bone marrow and the brain. Bone marrow adiposity may therefore have direct implications for brain health, yet the lack of in vivo studies in humans limits our understanding of such interplay. Here, we exploit large magnetic resonance imaging (MRI) datasets to study bone marrow adiposity and its association with brain and body traits. We trained an artificial neural network to localise calvarial bone marrow in T1-weighted 3T MRI head scans. Validation in two independent samples confirmed high accuracy of our approach to semi-quantitatively measure calvarial bone marrow adiposity in vivo. Our analyses revealed sex-dimorphic age trajectories in line with earlier work from non-calvarial bone marrow. Next, we studied the genetic architecture of the calvarial bone marrow and revealed its high heritability in single-nucleotide polymorphism and twin data. We identified 41 genetic loci significantly associated with the calvarial bone marrow, including a sex-specific genetic effect of the estrogen receptor locus. By integrating mapped genes with existing bone marrow single-cell RNA sequencing data, we revealed patterns of adipogenic lineage differentiation and lipid loading. Finally, we identified significant genetic correlation with several heritable human traits, including general cognitive ability and Parkinson’s disease. Our method for quantifying calvarial bone marrow adiposity from MRI head scans enables a significant advance in our understanding of the genetic and cellular drivers of bone marrow adiposity in humans. This contributes to the groundwork needed to elucidate its function and creates an opportunity to study its effects on other organs such as bone, blood, and brain.
Competing Interest Statement
OAA has received speaker’s honorarium from Lundbeck and Sunovion, and is a consultant to HealthLytix. Other authors report no competing interests.
Funding Statement
We acknowledge the following funding sources. TK: RCN (276082, 323961). TH: RCN (295679). OAA: RCN (223273) and EU’s H2020 RIA (grant 847776). LTW: EU H2020 ERC StG (Grant 802998); RCN (223273, 249795, 248238, 286838); the South-Eastern Norway Regional Health Authority (2014097, 2015044, 2015073, 2016083, 2018037, 2018076. 2019101). We would like to thank everyone involved with the collection and sharing of imaging and genetics data used in this study. Analysis was performed on the TSD computer facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (USIT) and on resources provided by UNINETT Sigma2 - the National Infrastructure for High Performance Computing and Data Storage in Norway.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We obtained data from various cohorts where each data collection has been approved by the respective ethics boards and all participants gave informed written consent. Specifically, the National Health Service National Research Ethics Service gave ethical approval to the UK Biobank (ref. 11/NW/0382), the Washington University institutional review board gave ethical approval to the Human Connectome Project, and the local ethics committee at Hangzhou Normal University gave ethical approval to the HNU study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Content type: Full paper
Data Availability
This research has been conducted using the UK Biobank Resource (access code 27412), the Human Connectome Project, and data from Hangzhou Normal University as part of the data provided by the Consortium for Reliability and Reproducibility. Human Connectome Project data was provided by the WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. We obtained GWAS summary statistics from the following consortia: Genetic Factors for Osteoporosis Consortium, Genetic Investigation of ANthropometric Traits, ICBP International Consortium for Blood Pressure, Diabetes Genetics Replication And Meta-analysis Consortium, Coronary Artery Disease Genome-wide Replication and Meta-analysis Consortium, Complex Traits Genetics Consortium, Social Science Genetic Association Consortium, International Multiple Sclerosis Genetics Consortium, International Parkinson Disease Genomics Consortium, Psychiatric Genomics Consortium. BMA GWAS summary statistics are available on the FUMA website (ID XXXX) [made public upon acceptance]
